Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Dec 2021 for Dicerna Pharmaceuticals Inc, €113k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Martin I. Freed: trading record in brief
This profile gathers the share dealings of Martin I. Freed across 2 companies, led by Dicerna Pharmaceuticals Inc and Solid Biosciences Inc. Between 25 July 2019 and 28 December 2021, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 29 December 2021 with a transaction (€113k) in Dicerna Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Martin I. Freed
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
3,333 shares@ US$38.25100.0% of flowCommon StockSEC:0001399529-21-000199:0
3,333 sharesCommon StockSEC:0001399529-21-000108:0
2 of 2 declarations
